Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05998031 · ClinicalTrials.gov registry record · NA

A Mechanistic Study to Investigate tDCS and Working Memory in MCI Patients

A NA study of Cognitive Impairment and Cognitive Decline, sponsored by University of Florida.

Recruiting
Registry status
NA
Development phase
110
Enrollment target
1
Study location

NCT05998031 is a NA study of Cognitive Impairment and Cognitive Decline that is actively recruiting participants, run by University of Florida. The registered enrollment target is 110 participants, below the 665-participant average among 105 other Cognitive Impairment trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05998031, a NA study of Cognitive Impairment and Cognitive Decline, is actively recruiting participants, sponsored by University of Florida.

RECRUITING
Registry status
NA
Development phase
110 participants
Enrollment target
1
Study location

Study Summary

The current study is a mechanistic study to evaluate working memory gains from application of transcranial direct current stimulation (tDCS) in older adults with mild cognitive impairments (MCI) compared to cognitively healthy control

Interventions

  • DEVICE Sham tDCS
  • DEVICE Active tDCS

Study Locations (1)

Florida

  • University of Florida - Gainesville

Trial Details

FieldValue
Enrollment Target 110 participants
Start Date 2024-04-24
Est. Completion 2029-11-30
Phase NA

Sponsor

University of Florida

1,106 total trials

What the Registry Record Tells You About NCT05998031

The ClinicalTrials.gov registry entry for NCT05998031 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 665-participant average among 105 other Cognitive Impairment trials with a reported enrollment target (83% lower). The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Cognitive Impairment appearing as the primary indexed condition, and to 2 interventions - of which Sham tDCS is the first listed.

NCT05998031 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT05998031 about?

NCT05998031 is a clinical study titled "A Mechanistic Study to Investigate tDCS and Working Memory in MCI Patients". The current study is a mechanistic study to evaluate working memory gains from application of transcranial direct current stimulation (tDCS) in older adults with mild cognitive impairments (MCI) compared to cognitively healthy control

What is the current status of trial NCT05998031?

This trial is currently recruiting. It is a NA study. The enrollment target is 110 participants. The study started on 2024-04-24. Estimated completion is 2029-11-30.

What conditions does trial NCT05998031 study?

This clinical trial studies the following conditions: Cognitive Impairment, Cognitive Decline.

What interventions are being tested in trial NCT05998031?

The interventions under investigation include: Sham tDCS (DEVICE), Active tDCS (DEVICE).

Who is sponsoring clinical trial NCT05998031?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05998031 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cognitive Impairment

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.